[Risk of community acquired pneumonia in patients with diabetes mellitus: Review].
G L IgnatovaE V BlinovaS V StruchM A SyrochkinaPublished in: Terapevticheskii arkhiv (2022)
The article for the first time provides a relatively comprehensive overview of the main aspects of the epidemiology and clinical features of infectious pathology, i.e., community-acquired pneumonia, as comorbid and aggravating conditions in patients with type 1 and type 2 diabetes mellitus. Risk factors and pathogenetic patterns of infectious processes development, as well as the special etiological role of pneumococcal infection in this group of patients, are considered. Particular attention is paid to the possibilities of and approaches to the primary prevention of vaccine-preventable infections as the causes of the development of community-acquired pneumonia and invasive diseases in patients with diabetes mellitus with a review of international studies, guidelines, and local experience data in pneumococcal infection immunization.
Keyphrases
- community acquired pneumonia
- risk factors
- end stage renal disease
- glycemic control
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- type diabetes
- working memory
- peritoneal dialysis
- metabolic syndrome
- cardiovascular disease
- big data
- machine learning
- patient reported
- adipose tissue
- insulin resistance
- adverse drug
- cardiovascular risk factors